Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs ACM✓SelectedUSD · ACMGSK vs ACM performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs ACM

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+97.1%
ACM return
+124.1%
Excess return
-27.1%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioACMExcessAlpha
1D-0.1%-2.1%+1.9%+0.3%
7D-5.3%+11.6%-16.9%-7.5%
30D-3.7%+32.2%-35.9%-8.9%
3M-7.3%+21.3%-28.6%-11.0%
6M-4.2%+11.1%-15.4%-6.8%
YTD+0.9%-16.1%+17.0%+3.1%
1Y+7.3%-24.7%+31.9%+12.0%
3Y+52.7%-6.2%+58.9%+50.2%
5Y+40.1%+13.5%+26.6%+30.6%
All+97.1%+124.1%-27.1%+50.3%

Cumulative growth

Daily Returns

Daily percentage return beside ACM.

Daily Out/Under-Performance

Portfolio return minus ACM return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × ACM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded ACM wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling